OTC$LIANY

Lianbio-Adr · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Headline financials

EPS (adj)

-$1.98

No prior period
Capital Expenditures

$551K

No prior period
Free Cash Flow

-$49.4M

No prior period
Net Income

-$12.7M

No prior period
Operating Income

-$9.2M

No prior period
Cash & Equivalents

$254M

No prior period
Total Assets

$279M

No prior period
Stock-Based Comp

$2.92M

No prior period

Revenue & EPS history

Lianbio-Adr · Revenue · Quarterly

$0

Q4 2024
Beat estimate in 0 of 1 quarters(0%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

+8.4%

Avg return

Earnings day

+8.4%

Avg return

5 days after

-3.1%

Avg return

30 days after

77%

10 / 13 earnings

Positive

+17.7%

Q4 2020

Best reaction

-4.1%

Q1 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2024-2.2%-6.7%-7.4%
Q3 2023+0.7%+1.5%+4.2%
Q2 2023+2.7%+0.0%-9.7%
Q1 2023-4.1%+4.6%+17.7%
Q4 2022-1.2%+17.4%+18.0%
Q3 2022+17.5%+38.9%+7.1%
Q2 2022+11.1%-1.5%-3.0%
Q1 2022+9.3%+29.8%+28.4%
Q4 2021+3.9%+26.1%+7.3%
Q2 2021+17.7%+0.4%-17.3%
Q3 2021+17.7%+0.4%-17.3%
Q4 2020+17.7%+0.4%-17.3%
Q1 2021+17.7%-2.4%-50.4%
Q3 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro